Skip to main content
SpringerLink
Log in

Epidemiology of Budd–Chiari Syndrome

  • Chapter
  • First Online:
Budd-Chiari Syndrome

Abstract

Budd-Chiari syndrome (BCS) is a rare but severe liver disorder, with low incidence and prevalence in the general population. The incidence reported in the literature ranges from 0.2 to 4.1 cases per million inhabitants per year, with an estimated prevalence of 2.4–7.7 per million inhabitants in Asian countries and of 1.4–4.0 per million inhabitants in Western countries. A predominance of females was reported in the West (52–69%), while in Asian studies males were more frequently affected (48–70%). Patients with BCS tend to be younger than patients with splanchnic vein thrombosis in other sites or venous thromboembolism, with wide variability reported in different countries (e.g. Pakistan, Nepal, Egypt mid-twenties vs USA, Australia, Italy and Denmark in the late-40s/early-50s). Finally, prevalence of BCS in patients with different risk factors (such as myeloproliferative neoplasm, paroxysmal nocturnal haemoglobinuria, Behçet’s disease or liver diseases) is highly variable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64(1):179–202.

    Article  Google Scholar 

  2. Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol. 2007;13(13):1912–27.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12(Suppl 1):168–80.

    Article  PubMed  Google Scholar 

  4. Li Y, De Stefano V, Li H, Zheng K, Bai Z, Guo X, et al. Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018;43(4):468–74. https://doi.org/10.1016/j.clinre.2018.10.014. pii: S2210-7401(18)30230-4 [Epub ahead of print] PubMed PMID: 30528513.

    Article  PubMed  Google Scholar 

  5. Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology. 1991;13:650–5.

    Article  CAS  PubMed  Google Scholar 

  6. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995;22(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  7. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver Int. 2009;29(2):253–9.

    Article  PubMed  Google Scholar 

  8. Ki M, Choi HY, Kim KA, Kim BH, Jang ES, Jeong SH. Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study. Liver Int. 2016;36(7):1067–73.

    Article  PubMed  Google Scholar 

  9. Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost. 2017;117(4):794–800.

    Article  PubMed  Google Scholar 

  10. Ollivier-Hourmand I, Allaire M, Goutte N, Morello R, Chagneau-Derrode C, Goria O, et al. The epidemiology of Budd-Chiari syndrome in France. Dig Liver Dis. 2018;50(9):931–7.

    Article  PubMed  Google Scholar 

  11. Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, et al. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44(11–12):1152–67.

    Article  CAS  PubMed  Google Scholar 

  12. De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis. 2011;3(1):e2011063.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, et al. Budd-Chiari syndrome in China: a 30-year retrospective study on survival from a single center. World J Gastroenterol. 2018;24(10):1134–43.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zhang W, Qi X, Zhang X, Su H, Zhong H, Shi J, et al. Budd-Chiari Syndrome in China: a systematic analysis of epidemiological features based on the Chinese Literature Survey. Gastroenterol Res Pract. 2015;2015:738548.

    PubMed  PubMed Central  Google Scholar 

  15. Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, et al. Redefining Budd-Chiari syndrome: a systematic review. World J Hepatol. 2016;8(16):691–702.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Derman BA, Kwaan HC. Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis. Semin Thromb Hemost. 2015;41(5):503–13.

    Article  PubMed  Google Scholar 

  17. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010;8(2):200–5.

    Article  PubMed  Google Scholar 

  18. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–75.

    Article  PubMed  Google Scholar 

  19. Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol. 2011;54(1):56–63.

    Article  PubMed  Google Scholar 

  20. Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol. 2008;14(18):2858–62.

    Article  PubMed  PubMed Central  Google Scholar 

  21. De BK, De KK, Sen S, Biswas PK, Das TK, Das S, et al. Etiology based prevalence of Budd-Chiari syndrome in eastern India. J Assoc Physicians India. 2000;48(8):800–3.

    CAS  PubMed  Google Scholar 

  22. Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11(2):170–9.

    Article  CAS  PubMed  Google Scholar 

  23. Sawant P, Vashishtha C, Nasa M, Parikh P, Patel J, Agasti A. Thrombophilia profile in Budd-Chiari syndrome and Splanchnic Vein Thrombosis: a study from Western India. J Assoc Physicians India. 2015;63(9):32–5.

    PubMed  Google Scholar 

  24. Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol. 2010;29(1):8–11.

    Article  PubMed  Google Scholar 

  25. Parkash O, Khan A, Hamid S. Clinical characteristics and outcome of Budd-Chiari syndrome at a tertiary care hospital in Pakistan. J Coll Physicians Surg Pak. 2017;27(5):301–4.

    PubMed  Google Scholar 

  26. Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome. Intern Med J. 2017;47(12):1361–7.

    Article  CAS  PubMed  Google Scholar 

  27. Sakr M, Abdelhakam SM, Dabbous H, Hamed A, Hefny Z, Abdelmoaty W, et al. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome. Liver Int. 2017;37(3):415–22.

    Article  CAS  PubMed  Google Scholar 

  28. Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, et al. Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol. 2011;17(42):4704–10.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Søgaard KK, Darvalics B, Horváth-Puhó E, Sørensen HT. Survival after splanchnic vein thrombosis: a 20-year nationwide cohort study. Thromb Res. 2016;141:1–7.

    Article  PubMed  CAS  Google Scholar 

  30. Li G, Huang Y, Tang S, Song Y, Liang H, Liu D, et al. A single-center retrospective study: clinical features of different types of Budd-Chiari syndrome in Chinese patients in the Hubei area. Vascular. 2018;26(1):80–9.

    Article  PubMed  Google Scholar 

  31. Sakr MA, Abdelkader N, Dabbous H, Eldorry A. Prevalence of portal vein thrombosis in Egyptian patients with Budd-Chiari syndrome. Indian J Gastroenterol. 2014;33(5):489–91.

    Article  PubMed  Google Scholar 

  32. Ageno W, Riva N, Schulman S, Bang SM, Sartori MT, Grandone E, et al. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry. Semin Thromb Hemost. 2014;40(1):99–105.

    PubMed  Google Scholar 

  33. Riva N, Ageno W, Schulman S, Beyer-Westendorf J, Duce R, Malato A, et al. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. Lancet Haematol. 2016;3(6):e267–75.

    Article  PubMed  Google Scholar 

  34. Shaikh MS, Shaikh MU, Adil SN, Khurshid M, Ahmed ZA. Clinico-pathological profile and outcomes of patients with polycythaemia vera, essential thrombocythaemia and idiopathic myelofibrosis: a tertiary care center experience from Southern Pakistan. J Ayub Med Coll Abbottabad. 2016;28(2):293–7.

    PubMed  Google Scholar 

  35. De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, et al. Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. Blood Cancer J. 2016;6(11):e493.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res. 2014;133(6):1052–5.

    Article  CAS  PubMed  Google Scholar 

  37. Van Bijnen ST, Van Heerde WL, Muus P. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost. 2012;10(1):1–10.

    Article  PubMed  CAS  Google Scholar 

  38. Poulou LS, Xila V, Rokas GI, Karianakis G, Bartzoudis D, Ziakas PD. Temporal trends in mortality rates from visceral vein thrombosis in paroxysmal nocturnal haemoglobinuria: an optimistic view. Thromb Haemost. 2008;99(3):642–5.

    Article  CAS  PubMed  Google Scholar 

  39. AlGhasham N, Abulkhair Y, Khalil S. Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: a single-center experience in Saudi Arabia. Cytometry B Clin Cytom. 2015;88(6):389–94.

    Article  CAS  PubMed  Google Scholar 

  40. Khan M, Ahmad SQ, Bashir M, Ahmed P, Ayyub M. Clinico-haematological features of paroxysmal nocturnal haemoglobinuria. J Coll Physicians Surg Pak. 2017;27(1):53–4.

    PubMed  Google Scholar 

  41. Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behçet’s disease. Gastroenterol Clin Biol. 2008;32(3):316–20.

    Article  CAS  PubMed  Google Scholar 

  42. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology. 2014;53(11):2018–22.

    Article  CAS  PubMed  Google Scholar 

  43. Seyahi E, Caglar E, Ugurlu S, Kantarci F, Hamuryudan V, Sonsuz A, et al. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated center. Semin Arthritis Rheum. 2015;44(5):602–9.

    Article  PubMed  Google Scholar 

  44. Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, et al. Immunosuppressants reduce venous thrombosis relapse in Behçet’s disease. Arthritis Rheum. 2012;64(8):2753–60.

    Article  CAS  PubMed  Google Scholar 

  45. Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, et al. Mortality in Behçet’s disease. Arthritis Rheum. 2010;62(9):2806–12.

    Article  CAS  PubMed  Google Scholar 

  46. Zöller B, Li X, Sundquist J, Sundquist K. Familial risks of unusual forms of venous thrombosis: a nationwide epidemiological study in Sweden. J Intern Med. 2011;270(2):158–65.

    Article  PubMed  Google Scholar 

  47. Karnsakul W, Ingviya T, Seaberg E, Laengvejkal P, Imteyaz H, Vasilescu A, et al. Ascites in children: a single-center experience of 27 years. J Pediatr Gastroenterol Nutr. 2017;64(1):83–8.

    Article  PubMed  Google Scholar 

  48. Poddar U, Thapa BR, Rao KL, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol. 2008;23(9):1354–7.

    Article  PubMed  Google Scholar 

  49. Topdagi O, Okcu N, Bilen N. The frequency of complications and the etiology of disease in patients with liver cirrhosis in erzurum. Eurasian J Med. 2014;46(2):110–4.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Aydoğdu S, Ozgenç F, Yurtsever S, Akman SA, Tokat Y, Yağci RV. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J Trop Pediatr. 2003;49(6):367–70.

    Article  PubMed  Google Scholar 

  51. Adukauskiene D, Dockiene I, Naginiene R, Kevelaitis E, Pundzius J, Kupcinskas L. Acute liver failure in Lithuania. Medicina. 2008;44(7):536–40.

    Article  PubMed  Google Scholar 

  52. Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6(3):339–45.

    Article  CAS  PubMed  Google Scholar 

  53. Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392–8.

    Article  PubMed  Google Scholar 

  54. Sakamoto S, Egawa H, Kanazawa H, Shibata T, Miyagawa-Hayashino A, Haga H, et al. Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl. 2010;16(10):1207–14.

    Article  PubMed  Google Scholar 

  55. Krishna Kumar G, Sharif K, Mayer D, Mirza D, Foster K, Kelly D, et al. Hepatic venous outflow obstruction in paediatric liver transplantation. Pediatr Surg Int. 2010;26(4):423–5.

    Article  CAS  PubMed  Google Scholar 

  56. Galloux A, Pace E, Franchi-Abella S, Branchereau S, Gonzales E, Pariente D. Diagnosis, treatment and outcome of hepatic venous outflow obstruction in paediatric liver transplantation: 24-year experience at a single centre. Pediatr Radiol. 2018;48(5):667–79.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta

    Nicoletta Riva

  2. Department of Medicine and Surgery, University of Insubria, Varese, Italy

    Walter Ageno

Authors
  1. Nicoletta Riva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter Ageno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter Ageno .

Editor information

Editors and Affiliations

  1. Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China

    Xingshun Qi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Riva, N., Ageno, W. (2020). Epidemiology of Budd–Chiari Syndrome. In: Qi, X. (eds) Budd-Chiari Syndrome. Springer, Singapore. https://doi.org/10.1007/978-981-32-9232-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9232-1_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9231-4

  • Online ISBN: 978-981-32-9232-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation